Vogligold 0.2 Tablet - Steris Healthcare PVT LTD………

Vogligold 0.2

Voglibose (0.2mg)

Vogligold 0.2 is an oral antidiabetic medication primarily used to manage Type 2 diabetes mellitus. It contains Voglibose(0.2mg), an alpha-glucosidase inhibitor that helps control blood glucose levels by delaying the absorption of carbohydrates in the intestines. Vogligold 0.2 is an effective treatment option for patients who need additional glycemic control, particularly those who experience postprandial hyperglycemia.

Composition

• Active Ingredient: Voglibose (0.2mg)
• Excipients: Microcrystalline cellulose, lactose monohydrate, magnesium stearate, and other inactive ingredients that ensure the stability and efficacy of the tablet.

Mechanism of Action

Voglibose, the active component of Vogligold 0.2, works by inhibiting the enzyme alpha-glucosidase in the small intestine. Alpha-glucosidase is responsible for breaking down complex carbohydrates into simple sugars, which are then absorbed into the bloodstream. By inhibiting this enzyme, Voglibose slows down the digestion and absorption of carbohydrates, resulting in a gradual rise in blood glucose levels post-meal. This helps prevent postprandial hyperglycemia, a common issue in Type 2 diabetes management.

Indications

Vogligold 0.2 is indicated for:

• Type 2 Diabetes Mellitus: Used to improve glycemic control in adults with Type 2 diabetes, particularly when diet, exercise, and other antidiabetic medications do not provide adequate control.
• Postprandial Hyperglycemia: Specifically effective in managing high blood sugar levels that occur after meals.

Dosage and Administration

• Standard Dosage: The typical starting dose is 0.2mg taken three times a day before meals. The dosage may be adjusted based on the patient’s needs and the prescribing physician’s advice.
• Administration: Vogligold 0.2 should be taken just before each meal. Tablets should be swallowed whole with a small amount of water.
• Dose Adjustments: Adjustments may be necessary based on the patient's response to treatment. Regular monitoring of blood glucose levels is essential to ensure optimal dosing.

Benefits

• Effective Postprandial Glycemic Control: Helps to manage and reduce post-meal blood sugar spikes, improving overall glycemic control.
• Weight Neutral: Unlike some antidiabetic medications, Voglibose does not typically cause weight gain, making it suitable for overweight or obese patients with Type 2 diabetes.
• Reduced Risk of Hypoglycemia: Compared to other antidiabetic medications, Voglibose has a lower risk of causing hypoglycemia.

Side Effects

While Vogligold 0.2 is generally well-tolerated, it may cause some side effects, including:

• Gastrointestinal Issues: Flatulence, diarrhea, and abdominal discomfort are common, particularly during the initial phase of treatment. These symptoms usually diminish over time as the body adjusts to the medication.
• Hypoglycemia: Although rare, hypoglycemia can occur, especially if Vogligold 0.2 is used in combination with other antidiabetic medications.
• Elevated Liver Enzymes: Regular monitoring of liver function tests is recommended as Voglibose can cause transient elevations in liver enzymes.

Precautions and Warnings

• Regular Monitoring: Patients should have their blood glucose levels regularly monitored to ensure the medication is effectively managing their diabetes.
• Contraindications: Not recommended for patients with a history of hypersensitivity to Voglibose or any of its components. Also contraindicated in patients with severe renal impairment, gastrointestinal disorders, or a history of chronic intestinal disease.
• Pregnancy and Nursing: The safety of Voglibose during pregnancy and breastfeeding has not been established. It should only be used if the potential benefits justify the potential risks.

Drug Interactions

• Other Antidiabetic Agents: When used in combination with other antidiabetic medications, there may be an increased risk of hypoglycemia.
• Digestive Enzyme Supplements: These may reduce the efficacy of Voglibose by enhancing the breakdown of carbohydrates.
• Medications Affecting Intestinal Motility: Drugs that affect intestinal motility may alter the absorption and effectiveness of Voglibose.

Conclusion

Vogligold 0.2, containing Voglibose, provides an effective solution for managing Type 2 diabetes mellitus, particularly in controlling postprandial hyperglycemia. Its mechanism of action helps to slow the digestion and absorption of carbohydrates, leading to better glycemic control without significant weight gain. With benefits such as effective post-meal blood glucose management, convenient dosing, and a lower risk of hypoglycemia, Vogligold 0.2 is a valuable addition to diabetes management. Regular monitoring and adherence to prescribed guidelines are crucial for maximizing the therapeutic benefits and minimizing potential side effects. Vogligold 0.2 remains an important option in the treatment of Type 2 diabetes, helping patients achieve better health outcomes and improved quality of life.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW